ArticleCadernos de saude publica2025
How does the cut-off point for grip strength affect the prevalence of sarcopenia and associated factors? Findings from the ELSI-Brazil Study.
Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Low 25(OH)Vitamin D levels are associated with nutritional risk and disease severity in outpatient individuals with advanced chronic liver disease.Journal of nutritional science · 2026Article
- Regional inequalities in Brazil and new approaches to measuring population aging.Cadernos de saude publica · 2026Article
- Functionality, Anthropometric Measurements, and Handgrip Strength in Community-Dwelling Older Adults.Healthcare (Basel, Switzerland) · 2025Article
- Rsearch progress on the relationship between aging and microbiota in sarcopenia.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to compare the prevalence of sarcopenia and associated factors with the definition of muscle weakness established using two different cut-off points for grip strength. We carried out a cross-sectional study with 7,065 participants (aged 50 or older) from the ELSI-Brazil Study. Sarcopenia was defined by the European Working Group on Sarcopenia in Older People (EWGSOP2) and two different cut-off points for grip strength to define weakness: < 27kg for men/< 16kg for women or < 36kg for men < 23kg for women. The prevalence of different sarcopenia status was estimated, and associations with sociodemographic, behavioral, and clinical factors were investigated using multinomial regression models. The mean age of participants was 61 years; 51.8% were women and 41.5% were at risk of malnutrition. By adopting the higher cut-off points (< 36kg/< 23kg) for the definition of weakness, the prevalence of probable sarcopenia and sarcopenia quadrupled (40.1% versus 10.6%; 5% versus 1.4%, respectively) and the prevalence of severe sarcopenia doubled (8.8 versus 3.9%). Nutritional status was associated with sarcopenia status, however the cut-off points < 36/< 23kg increased substantially the relative risk ratio between malnutrition and severe sarcopenia (RRR = 11.23 versus 6.45). In general, factors associated with sarcopenia status were similar irrespective of the cut-off point adopted. Higher cut-off points for the definition of weakness may be better for identifying sarcopenia, enabling early interventions to avoid adverse outcomes related to the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.